Factors Determining Retreatment Time Interval of Rituximab in Korean Patients With Rheumatoid Arthritis.

ABSTRACT: Unlike other biologic agents for rheumatoid arthritis (RA) that are administered at regular intervals even without flare, rituximab can be administered according to the timing of retreatment determined by the physician. Recently, there has been a tendency to prefer on-demand administration for disease flares rather than regular retreatment. We aimed to investigate the retreatment patterns of rituximab in patients with RA and to identify factors associated with extension of the time interval between retreatment courses. This study included RA patients on rituximab treatment who were enrolled in the Korean Rheumatology Biologics registry (KOBIO) or treated at Ajou University Hospital. Previous or current concomitant conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs), co

SUBMITTER: Kim JW 

PROVIDER: S-EPMC8581042 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature